Hospital, Pathology Lab Cost Burden Downplayed By GAO In TC Billing Review
This article was originally published in The Gray Sheet
CMS' annual recalibration of relative payment weights under PPS eventually would offset costs incurred by hospitals if labs were no longer able to bill directly to Medicare for certain pathology services, GAO finds
You may also be interested in...
HCFA delays until Jan. 1, 2001 its requirement that independent laboratories bill hospitals, rather than HCFA, for the technical component of outpatient pathology services. Originally intended to take effect Aug. 1, the requirement forces labs to bill multiple payers for one service. Delay follows lobbying effort by the American Hospital Association, the College of American Pathologists, and the National Rural Health Association, who informed the agency in a June 29 letter that "too many adjustments are being required of hospital billing and computer systems at this time to allow them to absorb this additional change"
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Commissioner Hahn’s tweet announcing a return to inspections, while not a new policy, may be signal that FDA understands sponsor concerns with the agency’s limited ability to conduct onsite inspections. Effort may be aimed at reassuring industry even as CRLs related to manufacturing increase.